글로코스 (GKOS) 주가

글로코스(GKOS)는 NYSE에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $159.22 (-1.36%), 시가총액 $8.46B, 52주 최저~최고 $74.67 ~ $144.01.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with

핵심 지표

• 현재가: $159.22 (-1.36%)
• 시가총액: $8.46B
• 52주 최저~최고: $74.67 ~ $144.01
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NYSE

글로코스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

글로코스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.2667

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 11.69
• 순이익률: -0.34%
• 영업이익률: -0.13%

자주 묻는 질문